Snapshot
The The time-limited conditional approval system for regenerative medicines pathway has been developed by the Pharmaceuticals and Medical Devices Agency of Japan.
This pathway accelerates the regulatory review process.
Info not found
The The time-limited conditional approval system for regenerative medicines pathway has been developed by the Pharmaceuticals and Medical Devices Agency of Japan.
This pathway accelerates the regulatory review process.
Info not found